Mr. Ravi S. started the discussion by quoting “Don’t invest for the sake of making money, but to gain an understanding of the market.” By taking the example of the pharmaceutical sector he is closely associated to, he explained concentrated vs. diversified portfolio. According to him, all guidelines need to be strictly followed while considering each of them.
He went on to explain the process related details while making investments. He mentioned that the duration depends on the nature of the investments. The holding period depends on the nature of stocks you are holding in the firm. Right issue needs to be carefully considered while going through with the decision. He further elaborated the investment decisions by citing an example of the life cycle of the drug which goes through various stages namely pre-clinical, clinical, NDA Review, Post marketing, launch, generic.
He went on to explain the road ahead for the pharmaceutical sector, through which he explained the important considerations like “Am I paying too much?.” Here, we mentioned that more than numbers, judgment and expertise matter while making investments.
While considering investments in a start-up, sustenance with consistency is a takeaway. He also explained few standpoints including government’s involvement in policy making. He said that the government looks at it holistically, not based on individual investor’s interest.
He also explained certain concerns while making investment decisions, few of which include life cycle phase wherein it possibly still be in early investment phase involving high R&D cost. Management’s strategy of in-organic growth, low tax%- take has its subsidiaries in countries where they book R&D expenses and outspoken management i.e. the number of media interactions include some of the other concerns. He ended the discussion by quoting wise quoting as an requisite to good investment decisions.